These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 20070246
1. Gilbert-Meulengracht's syndrome and pharmacogenetics: is jaundice just the tip of the iceberg? Strassburg CP. Drug Metab Rev; 2010 Feb; 42(1):168-81. PubMed ID: 20070246 [Abstract] [Full Text] [Related]
3. [From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II]. Drenth JP, Peters WH, Jansen JB. Ned Tijdschr Geneeskd; 2002 Aug 10; 146(32):1488-90. PubMed ID: 12198827 [Abstract] [Full Text] [Related]
4. Molecular pathology of Crigler-Najjar type I and II and Gilbert's syndromes. Sampietro M, Iolascon A. Haematologica; 1999 Feb 10; 84(2):150-7. PubMed ID: 10091414 [Abstract] [Full Text] [Related]
5. Crigler-Najjar syndrome type I in a Turkish newborn caused by a novel mutation and Gilbert type genetic defect. Yildiz D, Alan S, Kilic A, Yaman A, Erdeve O, Kuloglu Z, Atasay B, Arsan S. Genet Couns; 2013 Feb 10; 24(3):273-7. PubMed ID: 24341141 [Abstract] [Full Text] [Related]
6. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR. Hum Mutat; 2000 Oct 10; 16(4):297-306. PubMed ID: 11013440 [Abstract] [Full Text] [Related]
8. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment. Lankisch TO, Behrens G, Ehmer U, Möbius U, Rockstroh J, Wehmeier M, Kalthoff S, Freiberg N, Manns MP, Schmidt RE, Strassburg CP. J Hepatol; 2009 May 10; 50(5):1010-8. PubMed ID: 19303655 [Abstract] [Full Text] [Related]
9. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects. Takeuchi K, Kobayashi Y, Tamaki S, Ishihara T, Maruo Y, Araki J, Mifuji R, Itani T, Kuroda M, Sato H, Kaito M, Adachi Y. J Gastroenterol Hepatol; 2004 Sep 10; 19(9):1023-8. PubMed ID: 15304120 [Abstract] [Full Text] [Related]
14. Liver bilirubin UDP-glucuronosyltransferase activity in chronic nonhemolytic unconjugated hyperbilirubinemia of adults. Watanabe A, Wakabayashi H, Kuwabara Y, Yamamoto H, Hattori S, Tsuji T. Res Exp Med (Berl); 1998 Apr 10; 197(6):329-36. PubMed ID: 9638795 [Abstract] [Full Text] [Related]
15. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP. N Engl J Med; 1995 Nov 02; 333(18):1171-5. PubMed ID: 7565971 [Abstract] [Full Text] [Related]
16. Crigler-Najjar Syndrome Type II Diagnosed in a Patient with Jaundice Since Birth. Liaqat A, Shahid A, Attiq H, Ameer A, Imran M. J Coll Physicians Surg Pak; 2018 Oct 02; 28(10):806-808. PubMed ID: 30266131 [Abstract] [Full Text] [Related]
18. Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia. D'Apolito M, Marrone A, Servedio V, Vajro P, De Falco L, Iolascon A. Haematologica; 2007 Jan 02; 92(1):133-4. PubMed ID: 17229650 [Abstract] [Full Text] [Related]